GLOSSARY

Creatine and Resistance Training uses creatine alongside resistance training, where increased training capacity can contribute to adaptation over time.

Creatine supplementation can increase muscle creatine and phosphocreatine availability, supporting rapid ATP regeneration during repeated high-intensity work. Creatine monohydrate is the best-established supplemental form; a more elaborate name does not prove superior effectiveness. Benefits are particularly relevant to suitable high-intensity training and resistance-training adaptation, while individual responses vary. Early body-mass gain can include intracellular water and should not be described entirely as newly built muscle. Health context and product quality still matter despite the substantial evidence base.

A creatine loading approach increases stores more rapidly, while a lower daily intake can increase stores more gradually. Loading is not required for every user, and maintenance aims to sustain elevated stores rather than create an immediate stimulant effect. Consistent intake and the training context matter more than asserting one mandatory minute for consumption. Co-ingestion may influence retention, but extra sugar or multiple products are not automatically necessary. Evaluate body-mass changes in relation to the actual sport and competition demands.

Apparent individual responses combine biological variation, measurement error, expectations and changes in training or diet. A person classified as a nonresponder after one noisy test may not have a stable absence of benefit. Use repeated, relevant observations under comparable conditions and consider starting nutrient status or habitual intake. Genetic mechanisms can be informative without making a commercial genetic test a validated prescription. Individualization should improve a practical decision, not turn uncertain differences into permanent athlete labels.

Supplement safety depends on ingredient, dose, duration, health status and other exposures. Natural origin does not guarantee safety, and absence of a reported adverse event in a small trial does not establish long-term safety. Medication interactions, pregnancy, age and kidney or liver disease can change the decision. Distinguish an event occurring during use from a causally established adverse effect. New or severe symptoms require stopping the suspect exposure and appropriate assessment rather than increasing the dose to overcome poor tolerance.

Label accuracy, ingredient identity, potency, contamination control and manufacturing traceability are separate aspects of quality. A proprietary blend may conceal the amount of each ingredient, preventing comparison with research. A certificate of analysis applies to specified tests and samples, not every possible hazard. Verify the exact product and batch in an independent certification program when relevant. Good manufacturing practice and third-party testing can reduce certain risks without proving efficacy or guaranteeing that every batch is free of prohibited substances.